Nature, 2020 · DOI: 10.1038/s41586-020-2795-6 · Published: November 1, 2020
Spinal cord injury in adult mammals typically leads to scar formation and limited axon regeneration. This study found that neonatal mice, however, exhibit scar-free healing and axon regrowth after spinal cord injury. Microglia, a type of immune cell in the central nervous system, play a critical role in this scar-free healing process in neonates. Depleting microglia disrupts healing and stalls axon regrowth. Neonatal microglia transiently secrete fibronectin to form extracellular matrix bridges and express peptidase inhibitors that resolve inflammation, contributing to the scar-free healing. Transplantation of neonatal microglia or adult microglia treated with peptidase inhibitors into adult spinal cord lesions improves healing and axon regrowth.
The findings suggest that strategies mimicking neonatal microglia activity, such as fibronectin delivery or peptidase inhibitor treatment, could promote scar-free healing in adult spinal cord injuries.
Further research into the molecular mechanisms of neonatal microglia could uncover new therapeutic targets for spinal cord injury and other neurological disorders.
The study highlights the importance of transient inflammatory responses and the role of peptidase inhibitors in promoting tissue repair and regeneration.